NextFin news, The European Space Agency (ESA) announced in November 2025 the development of a pioneering bioreactor technology under its HOBI-WAN project that produces edible protein from astronauts' exhaled air and urine. This project, set to be tested aboard the International Space Station (ISS), utilizes a microbe called Xanthobacter that consumes hydrogen, carbon dioxide, and nitrogen—derived from recycled astronaut waste and water electrolysis—to produce a protein-rich biomass. This biomass, after drying, becomes a neutral-tasting, B-vitamin packed powder consisting of 65-70% protein, comparable to soy or beef protein in composition. ESA's initiative aims to address the unsustainable cost and logistics of transporting freeze-dried foods for long-duration missions such as planned journeys to Mars.
The bioreactor compactly fits in a middeck locker size (similar to a microwave oven) and will perform in microgravity conditions—overcoming significant challenges related to gas-liquid mixing without buoyancy, which is a paradigm shift for fermentation technology. Astronauts aboard the ISS will monitor microbial growth samples to validate the efficacy and safety of the production process in space. ESA’s Chief Exploration Scientist Angelique Van Ombergen highlighted the project's goal to enhance autonomy, resilience, and well-being for humans in prolonged missions beyond Earth's orbit.
According to ESA and Solar Foods, the technology is powered by renewable energy sources such as solar panels splitting water to produce hydrogen and oxygen, sustainable even in extraterrestrial environments. Rather than shipping food from Earth, which can cost upwards of $1000 per pound, this in-situ protein generation drastically reduces payload mass and mission costs.
Extensive research in synthetic biology has underpinned this development, leveraging organisms adapted to low pressure and radiation conditions with optimized metabolic pathways for efficient carbon fixation and nitrogen utilization. ESA’s approach forms part of broader Bioregenerative Life Support Systems (BLSS) incorporating closed ecological loops—enabling oxygen regeneration, water recycling, and food production on Moon and Mars habitats, addressing key variables like radiation protection and stress resilience as outlined in the recent npj Microgravity publication by ESA-affiliated researchers in July 2025.
This innovation also aligns with the International Space Station’s ongoing experiments cultivating crops and microbes for nutritional supply, showing progress toward long-term sustainability. The HOBI-WAN experiment’s success would validate gas fermentation in microgravity, unlocking scalable production paradigms for deep space habitats. Challenges include ensuring safety from explosive gas mixtures and maintaining microbial viability in altered gravity, but ESA has engineered containment and process controls to mitigate these risks.
The broader implications for space missions include reducing dependency on Earth, fostering closed-loop bioeconomies, and offering new solutions to nutritional deficiencies observed in stored space foods. Moreover, technologies proven in space bioreactors may translate into terrestrial applications for sustainable protein production, contributing to resource-efficient food systems amid global pressures.
Forward-looking, ESA envisions integrating this protein source into astronauts' diets by the late 2020s, supporting Artemis lunar missions and forthcoming Mars expeditions, where resupply is limited or impossible. Combined with other synthetic biology advances—such as bio-manufacturing pharmaceuticals and radiation protection biomolecules—these developments promise self-sustained extraterrestrial habitats enhancing human health and mission resilience.
Financially, the adoption of in-situ protein production is projected to significantly reduce logistical costs for missions estimated to require 12 to 26 metric tons of food and water per crew for multi-year Mars missions, where every kilogram launched from Earth incurs costs exceeding $100,000. This microbe-based approach is a scalable and less mass-intensive alternative, potentially reducing launch mass by over 85% for life support consumables.
In summary, Europe's microbe-based protein from astronaut waste project represents a vital technological leap in sustainable space exploration. It addresses critical challenges of cost, mass, and crew health, and is rooted in advanced synthetic biology. The success of HOBI-WAN may set a precedent for closed-loop life-support systems critical for humanity's next giant leap into deep space exploration while echoing back benefits for sustainable food technology on Earth.
According to ESA’s announcements and research published in npj Microgravity, this initiative marks an unprecedented fusion of biotechnology and aerospace engineering targeting long-term extraterrestrial missions under the current global leadership of the United States under President Donald Trump’s administration, which prioritizes sustained human presence beyond Earth orbit.
Explore more exclusive insights at nextfin.ai.